Image: IANS

Covaxin effectively neutralises Alpha, Delta variants: US top body

Washington | Covaxin’s Covid-19 jab, developed and manufactured by Hyderabad-based Bharat Biotech, generates antibodies that can effectively neutralise the Alpha (B117) and Delta (B1617) variants of SARS-CoV-2, the virus causing Covid-19, the US National Institutes of Health has said citing results from two studies of blood serum from people who received the shots. Covaxin comprises a […]

Covishield, Covaxin work against Alpha-Beta-Gamma-Delta variants: DG-ICMR

New Delhi | Director General of Indian Council for Medical Research (ICMR), Balram Bhargava said that Covishield and Covaxin work against Alpha, Beta, Gamma and Delta variants of SARS-CoV-2, while their effectiveness against the Delta plus variant is being tested. Bhargava mentioned that the reduction of neutralisation capabilities of vaccines with different variants is based on […]

Representational Image | FreePik

Efficacy of Covaxin, Covishield, Sputnik V more or less equivalent: Dr Randeep Guleria

New Delhi | Data available till now shows clearly that efficacy of all vaccines — whether Covaxin, Covishield or Sputnik V — are more or less equivalent, AIIMS Director Dr Randeep Guleria said amid rumours about differentiated abilities of Covid-19 vaccines available in India in terms of production of antibodies or higher seropositivity rate. “We should […]

Image | IANS

Haffkine Biopharma to produce 22.8 cr doses of Covaxin per annum

New Delhi | The Centre on Wednesday took steps to accelerate domestic vaccine production. Mumbai-based Haffkine Biopharma will produce 22.8 crore doses per annum of Covaxin under technology transfer arrangement with Bharat Biotech. With the aim of vaccinating the entire eligible population at the earliest, domestic vaccine production is being steadily ramped up in the country […]

Representational Image | Freepik

Covaxin trials on children likely from next month

Hyderabad | Bharat Biotech may commence paediatric trials of its Covid-19 vaccine Covaxin from June, a senior company official said. The vaccine maker has already received permission to carry out trials on children aged 2-18 years. Bharat Biotech’s Business Development & International Advocacy Head, Dr Raches Ella, exuded confidence that vaccine for kids may get the […]

Image | IANS

Covaxin production to be ramped up by 200 million doses

Hyderabad | Bharat Biotech on Thursday announced the quick ramp up of additional manufacturing capacities for Covid-19 vaccine Covaxin by an additional 200 million. The manufacturing capacities for India’s first indigenous Covid vaccine have been ramped up at Chiron Behring Vaccines, a wholly-owned subsidiary of Bharat Biotech at Ankleshwar, Gujarat. The company plans to produce 200 […]